wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38124761-37137E33-D195-47E3-A679-6B8B2A497993
Q38124761-37137E33-D195-47E3-A679-6B8B2A497993
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38124761-37137E33-D195-47E3-A679-6B8B2A497993
Top 10 developments in lupus nephritis.
P2860
Q38124761-37137E33-D195-47E3-A679-6B8B2A497993
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38124761-37137E33-D195-47E3-A679-6B8B2A497993
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4aa8b4878e84f6330a347e37b50ae654cf4d2b8c
P2860
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.